FindTrial
Sign In

Impact of two oral iron supplementation regimens (intermittently and continuously/daily) for prevention of anaemia in pregnancy in women with normal haemoglobin levels

Impact of intermittent versus continuous oral iron supplementation in Non-anaemic pregnant women in a tertiary care hospital-randomized controlled trial - INCOIRON

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/12/002223
Enrollment
150
Registered
2011-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ferrous fumarate with 98.6 mg of elemental iron (Intermittent group): One capsule containing 98.6g mg elemental iron as ferrous fumarate at night time. duration: Throughout pregnancy, s

Sponsors

KASTURBA MEDICAL COLLEGE MANIPAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Antenatal women (booked cases attending antenatal clinic in department of obstetrics and gynecology and plan delivery in our hospital) between Period of gestation from 13 to 16 weeks and Haemoglobin more than or equal to 10.5 g/dl as per the CDC recommendations

Exclusion criteria

Exclusion criteria: Suspected acute infection (Upper respiratory tract and urinary tract infections, Gastroenteritis), Pre-existing chronic illness, like chronic renal disease, hepatic cirrhosis, viral hepatitis, Inflammatory bowel disease, Recent blood transfusion, Beta-thalassemia and other haemoglobinopathies

Design outcomes

Primary

MeasureTime frame
Haemoglobin (more than 10.5 g/dl)Timepoint: Haemoglobin at 28 and 38 weeks gestation—

Secondary

MeasureTime frame
Side-effects of oral iron, Pre-eclampsia, IUGR in 3rd trimester, Preterm labor, birth weight, placenta weightTimepoint: During antenatal check-ups, After delivery—

Countries

India

Contacts

Public ContactLAVANYA RAI

KASTURBA MEDICAL COLLEGE, MANIPAL

railavanyaanizer70@gmail.com0820-2922211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026